Member States should be able to allow the exceptional use of veterinary medicinal products without a marketing authorisation where it is necessary to respond to Union-listed diseases or emerging diseases and where the health situation in a Member State so requires.
Ba cheart cead a bheith ag na Ballstáit táirgí íocshláinte tréidliachta a úsáid go heisceachtúil gan údarú margaíochta nuair is gá chun freagairt a thabhairt ar ghalair atá liostaithe san Aontas nó ar ghalair atá ag teacht chun cinn agus nuair is gá é sin a dhéanamh i ngeall ar chúrsaí sláinte i mBallstát.